OMX Nordic 40
|
2 350,94
|
-7,79
|
-0,33 %
|
Analysen zu OMX Nordic 40-Werten
| 11.09.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 10.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.09.24 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 10.09.24 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Sell | UBS AG | |
| 09.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 06.09.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.09.24 | Volvo AB Buy | Jefferies & Company Inc. | |
| 03.09.24 | Volvo AB Sector Perform | RBC Capital Markets | |
| 03.09.24 | ABB Sector Perform | RBC Capital Markets | |
| 03.09.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.08.24 | Hennes & Mauritz AB Overweight | Barclays Capital | |
| 28.08.24 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 28.08.24 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
| 28.08.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.08.24 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 27.08.24 | Hennes & Mauritz AB Outperform | RBC Capital Markets | |
| 27.08.24 | Volvo AB Buy | Goldman Sachs Group Inc. | |
| 15.08.24 | AstraZeneca Sell | UBS AG | |
| 15.08.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 14.08.24 | Volvo AB Buy | Jefferies & Company Inc. | |
| 13.08.24 | AstraZeneca Sell | UBS AG | |
| 13.08.24 | Hennes & Mauritz AB Buy | Deutsche Bank AG | |
| 09.08.24 | Novo Nordisk Neutral | UBS AG | |
| 08.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 08.08.24 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
| 07.08.24 | Novo Nordisk Underperform | Bernstein Research | |
| 07.08.24 | Novo Nordisk Neutral | UBS AG | |
| 07.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.08.24 | A.P. Moeller - Maersk A-S Neutral | Goldman Sachs Group Inc. | |
| 07.08.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.08.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.08.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.08.24 | Novo Nordisk Neutral | UBS AG | |
| 31.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.07.24 | Volvo AB Sector Perform | RBC Capital Markets | |
| 30.07.24 | ABB Buy | Goldman Sachs Group Inc. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.